Spero Therapeutics Inc (SPRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -68,566 | 22,806 | -46,415 | -89,756 | -78,280 |
| Depreciation Amortization | 2 | 367 | 869 | 646 | 761 |
| Accounts receivable | 46,351 | -95,742 | 0 | N/A | N/A |
| Accounts payable and accrued liabilities | 5,928 | 761 | -484 | -53 | -2,975 |
| Other Working Capital | 36,284 | -70,375 | 22,087 | 12,862 | -13,464 |
| Other Operating Activity | -43,443 | 109,188 | 16,212 | 11,954 | 8,086 |
| Operating Cash Flow | $-23,444 | $-32,995 | $-7,731 | $-64,347 | $-85,872 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 33,807 | 7,633 | 10,627 |
| PPE Investments | N/A | N/A | N/A | N/A | -157 |
| Other Investing Activity | 0 | 0 | 0 | 39 | 0 |
| Investing Cash Flow | $N/A | $N/A | $33,807 | $7,672 | $10,470 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 221 | 24,932 | 9,281 | 80,849 |
| Other Financing Activity | 0 | 0 | -54,485 | 74,769 | 50,032 |
| Financing Cash Flow | $N/A | $221 | $-29,553 | $84,050 | $130,881 |
| Beginning Cash Position | 76,333 | 109,107 | 112,584 | 85,209 | 29,730 |
| End Cash Position | 52,889 | 76,333 | 109,107 | 112,584 | 85,209 |
| Net Cash Flow | $-23,444 | $-32,774 | $-3,477 | $27,375 | $55,479 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,444 | -32,995 | -7,731 | -64,347 | -85,872 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -157 |
| Free Cash Flow | -23,444 | -32,995 | -7,731 | -64,347 | -86,029 |